Le Lézard
Classified in: Health
Subject: TRI

Soin Neuroscience commences a clinical case series with Nuvectra's Algovita spinal cord stimulator for back pain



DAYTON, Ohio, March 8, 2018 /PRNewswire/ -- Soin Neuroscience, a biotech company based in Dayton, OH, has received IRB (institutional review board) approval to commence a clinical case series to study spinal cord stimulator algorithms in patients who suffer from back pain. Dr Amol Soin, a pain management physician and CEO of Soin Neuroscience, will be running the study in Dayton, OH. "I look forward to using Nuvectra's Algovita, and its powerful spinal cord stimulator system to treat patients with back pain. We will be trialing waveforms that are unique to Nuvectra's system. This is a small study that I hope will allow us to run additional larger studies. I think we can help a lot of people with back pain."

Dr. Amol Soin, founder and CEO of Soin Neuroscience, and pain management physician.

The study will be run in Dayton, OH. Patients who suffer from debilitating back may be considered good candidates for the study.

About Soin Neuroscience:

Soin Neuroscience (SNI) is a pharmaceutical startup company based in Dayton, OH that specializes in treating pain and other neurological conditions. Its lead compound, TV1001SR, is entering late stage trials to treat systemic sclerosis and diabetic peripheral neuropathy. SNI also has multiple other compounds in development including a way to restore functional motor and cognitive function after ischemic stroke, a method to treat intensive care unit myopathy, and is working on an option to treat Huntington's disease. The company was founded by Dr. Amol Soin who is also an inventor on most of the core technologies that are being developed. He can be reached at drsoin@soinneuroscience.com.

 (PRNewsfoto/Soin Neuroscience)

SOURCE Soin Neuroscience


These press releases may also interest you

at 22:12
The Alzheimer's Research and Prevention Foundation (ARPF) announced today that its paper, "Stress, Meditation, and Alzheimer's Disease Prevention: Where The Evidence Stands, Khalsa, DS (2015)," published in The Journal of Alzheimer's Disease (JAD)...

at 22:00
PureCircle filed a complaint in the U.S. District Court for the Central District of California against Sweegen, Inc.  PureCircle claims that Sweegen's Bestevia® Reb-M is infringing PureCircle's patent -- U.S. Patent No. 9,243,273, A Method for Making...

at 22:00
The health & fitness app uses the mobile marketing platform to drive user retention  CleverTap, a leading mobile marketing platform, today announced that HealthifyMe, India's largest and most loved health and fitness app, is using their advanced...

at 21:27
Hosted by Beijing Municipal Commission of Tourism Development (BMCTD), a series of activities for overseas influencers to experience Chinese medicine tours in Beijing was launched in Beijing in September 2018. The launching ceremony was held at...

at 21:00
LEHIGH VALLEY, Pa., Sept. 18, 2018 /PRNewswire-PRWeb/ -- For the second consecutive year, Azzur Labs has been named one of the Best Places to Work in PA. The awards program, created in 2000, is one of the first statewide programs of its kind in the...

at 21:00
DALLAS, Sept. 18, 2018 /PRNewswire-PRWeb/ -- Homecare Homebase, the leader in home health and hospice electronic health record (EHR) solutions today announced changes to its long-time partnership with McKesson Medical-Surgical Inc., a leader in home...




News published on 8 march 2018 at 18:18 and distributed by: